ArticleFrontiers in medicine2021

Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease.

Fabio Corsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.